Kyowa Kirin Co., Ltd. (KYKOF)

USD 16.05

(0.0%)

Total Assets Summary of Kyowa Kirin Co., Ltd.

  • Kyowa Kirin Co., Ltd.'s latest annual total assets in 2023 was 1025.94 Billion JPY , up 9.16% from previous year.
  • Kyowa Kirin Co., Ltd.'s latest quarterly total assets in 2024 Q2 was 1070 Billion JPY , up 0.39% from previous quarter.
  • Kyowa Kirin Co., Ltd. reported annual total assets of 939.88 Billion JPY in 2022, up 1.95% from previous year.
  • Kyowa Kirin Co., Ltd. reported annual total assets of 921.87 Billion JPY in 2021, up 15.05% from previous year.
  • Kyowa Kirin Co., Ltd. reported quarterly total assets of 1065.88 Billion JPY for 2024 Q1, up 3.89% from previous quarter.
  • Kyowa Kirin Co., Ltd. reported quarterly total assets of 979.69 Billion JPY for 2023 Q2, up 5.26% from previous quarter.

Annual Total Assets Chart of Kyowa Kirin Co., Ltd. (2023 - 2000)

Historical Annual Total Assets of Kyowa Kirin Co., Ltd. (2023 - 2000)

Year Total Assets Total Assets Growth
2023 1025.94 Billion JPY 9.16%
2022 939.88 Billion JPY 1.95%
2021 921.87 Billion JPY 15.05%
2020 801.29 Billion JPY 2.15%
2019 784.45 Billion JPY 5.72%
2018 741.98 Billion JPY 4.76%
2017 708.29 Billion JPY 1.6%
2016 697.16 Billion JPY -3.27%
2015 720.76 Billion JPY 0.23%
2014 719.13 Billion JPY -0.02%
2013 719.25 Billion JPY 5.88%
2012 679.34 Billion JPY 3.11%
2011 658.87 Billion JPY -5.32%
2010 695.86 Billion JPY 0.09%
2009 695.26 Billion JPY 76.43%
2008 394.08 Billion JPY 4.01%
2007 378.87 Billion JPY -1.43%
2006 384.38 Billion JPY 2.64%
2005 374.49 Billion JPY 3.71%
2004 361.09 Billion JPY -2.08%
2003 368.77 Billion JPY -14.26%
2002 430.11 Billion JPY -0.3%
2001 431.41 Billion JPY -0.59%
2000 433.95 Billion JPY 0.0%

Peer Total Assets Comparison of Kyowa Kirin Co., Ltd.

Name Total Assets Total Assets Difference
AstraZeneca PLC 100.97 Billion USD -916.023%
Bristol-Myers Squibb Company PFD CONV 2 95.15 Billion USD -978.134%
CSPC Pharmaceutical Group Limited 6.52 Billion USD -15625.626%
Clarus Therapeutics Holdings, Inc. 51.7 Million USD -1984006.908%
Novartis AG 99.94 Billion USD -926.507%
PT Kalbe Farma Tbk. 1.75 Billion USD -58233.857%